Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

AGM voting results

8 May 2024 12:12

RNS Number : 6416N
Aston Martin Lagonda Glob.Hldgs PLC
08 May 2024
Β 

Β 

Aston Martin Lagonda Global Holdings plc

Voting results of Annual General Meeting held on 8 May 2024

Β 

Aston Martin Lagonda Global Holdings plc ("the Company") announces that its Annual General Meeting held today electronically by audio webcast at 10.30 am, was successfully concluded. All resolutions put to the meeting were duly passed by shareholders by the majority required on a poll. The voting results are set out in the table below and the voting represents 70.09% of the issued share capital of 823,741,835 ordinary shares.

Aston Martin Lagonda Global Holdings plc - Poll Results by All Shareholders

RESOLUTION

VOTES

FORΒΉ

AGAINST

WITHHELDΒ²

TOTAL

Β 

Votes

%

Votes

%

Votes

Β 

1

Company's Annual Report and Accounts 2023

577,126,108

100.00

13,445

0.00

227,140

577,139,553

Β 

2

To approve the Directors' Remuneration Report

522,975,857

90.60

54,259,124

9.40

131,776

577,234,981

Β 

3

To re-elect Lawrence Stroll as a Director

548,993,304

95.10

28,262,209

4.90

111,245

577,255,513

Β 

4

To re-elect Amedeo Felisa as a Director

576,047,257

99.79

1,205,221

0.21

114,280

577,252,478

Β 

5

To re-elect Doug Lafferty as a Director

575,665,268

99.73

1,587,142

0.27

114,348

577,252,410

Β 

6

To re-elect Michael de Picciotto as a Director

567,807,553

98.36

9,445,092

1.64

114,113

577,252,645

Β 

7

To re-elect Robin Freestone as a Director

566,967,776

98.22

10,284,799

1.78

114,183

577,252,575

Β 

8

To re-elect Natalie Massenet as a Director

569,180,379

98.60

8,072,196

1.40

114,182

577,252,575

Β 

9

To re-elect Marigay McKee as a Director

574,401,338

99.51

2,851,073

0.49

114,346

577,252,411

Β 

10

To re-elect Franz Reiner as a Director

565,274,125

97.92

11,978,542

2.08

114,090

577,252,667

Β 

11

To re-elect Anne Stevens as a Director

560,502,423

97.10

16,750,247

2.90

114,088

577,252,670

Β 

12

To re-elect Ahmed Al-Subaey as a Director

567,806,313

98.36

9,446,506

1.64

113,734

577,252,819

Β 

13

To re-elect Sir Nigel Boardman as a Director

574,694,382

99.56

2,558,288

0.44

113,956

577,252,670

Β 

14

To re-elect Scott Robertson as a Director

565,272,790

97.92

11,979,782

2.08

114,185

577,252,572

Β 

15

To elect Daniel Li as a Director

553,706,985

95.92

23,546,553

4.08

113,014

577,253,538

Β 

16

To elect Cyrus Jilla as a Director

567,809,108

98.36

9,443,955

1.64

113,490

577,253,063

Β 

17

To elect Jean Tomlin as a Director

577,165,672

99.98

87,599

0.02

113,487

577,253,271

Β 

18

To re-appoint Ernst & Young LLP as auditor

Β 

577,223,893

99.99

36,433

0.01

106,432

577,260,326

Β 

19

To authorise the Audit & Risk Committee to determine the remuneration of the auditor

577,239,454

100.00

19,924

0.00

107,380

577,259,378

Β 

20

To authorise limited political donations

577,147,439

99.98

111,869

0.02

107,450

577,259,308

Β 

21

To authorise the Directors to allot shares

576,220,401

99.82

1,040,390

0.18

105,966

577,260,791

Β 

22

To authorise the Directors to disapply pre-emption rightsΒ³

574,275,243

99.68

1,823,467

0.32

1,268,047

576,098,710

Β 

23

To authorise Directors to further disapply pre-emption rights for acquisitions and specified capital investmentsΒ³

575,029,479

99.61

2,223,110

0.39

114,168

577,252,589

Β 

24

To authorise the Company to purchase own sharesΒ³

576,936,199

99.99

52,961

0.01

377,598

576,989,160

Β 

25

To reduce the notice of general meetingsΒ³

575,349,474

99.67

1,905,402

0.33

110,876

577,254,876

Β 

Β 

Β 

Β 

Notes:

Β 

ΒΉ Includes discretionary votes

Β² A vote withheld is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a Resolution

Β³ Resolutions 22 - 25 were special resolutions and the full text of all of the Resolutions are set out in the Notice of Annual General Meeting on the Company's website

Β 

Β 

These results will shortly be available on the Company's website atΒ www.astonmartinlagonda.com/investor/shareholder-informationΒ andΒ in accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business at an annual general meeting will be submitted to the National Storage Mechanism and will shortly be available for inspection atΒ  https://data.fca.org.uk/#/nsm/nationalstoragemechanism

Β 

Β 

Β 

Β 

Liz Miles

Company Secretary

Β 

Β 

Β 

Enquiries

Β 

Investors and Analysts

James Arnold Head of Investor Relations +44 (0) 7385 222347

james.arnold@astonmartin.com

Ella South Investor Relations Analyst +44 (0) 7776 545420

ella.south@astonmartin.com

Media

Β 

Kevin Watters Director of Communications +44 (0) 7764 386683

kevin.watters@astonmartin.com

Β 

Paul Garbett Head of Corporate & Brand +44 (0) 7501 380799

Communications paul.garbettt@astonmartin.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RAGAPMBTMTBMBBI
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.